Ascorbic acid plus gemcitabine (gem) and erlotinib (erl) in patients with metastatic pancreatic cancer (mPanc): Preliminary safety results.

High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

Case Medical Research ◽

10.31525/ct1-nct03908333 ◽

2019 ◽

Author(s):

Keyword(s):

Pancreatic Cancer ◽

Ascorbic Acid ◽

High Dose

A phase Ib/II trial of high dose ascorbic acid (AA) + paclitaxel protein bound (PP) + cisplatin (C) + gemcitabine (G) with digital spatial profiling (DSP) in patients (pts) with metastatic pancreatic cancer (MPC)

European Journal of Cancer ◽

10.1016/s0959-8049(20)31224-7 ◽

2020 ◽

Vol 138 ◽

pp. S55

Author(s):

D.D. Von Hoff ◽

G. Jameson

Keyword(s):

Pancreatic Cancer ◽

Ascorbic Acid ◽

High Dose ◽

Phase Ib ◽

Spatial Profiling

Abstract B27: A phase Ib/II trial of high-dose (HD) ascorbic acid (AA) + paclitaxel protein bound (PP) + cisplatin (C) + gemcitabine (G) in patients (pts) with metastatic pancreatic cancer (MPC)

10.1158/1538-7445.panca19-b27 ◽

2019 ◽

Author(s):

Gayle S. Jameson ◽

Erkut H. Borazanci ◽

Joshua Rabinowitz ◽

Karen Ansaldo ◽

Sarah LeGrand ◽

...

Keyword(s):

Pancreatic Cancer ◽

Ascorbic Acid ◽

High Dose ◽

Abstract CT163: A Phase Ib/II trial of high dose ascorbic acid (AA) + paclitaxel protein bound (PP) + cisplatin (C) + gemcitabine (G) in patients (pts) with metastatic pancreatic cancer (MPC)

10.1158/1538-7445.am2019-ct163 ◽

2019 ◽

Author(s):

Gayle S. Jameson ◽

Erkut H. Borazanci ◽

Joshua D. Rabinowitz ◽

David Propper ◽

Karen Ansaldo ◽

...

Keyword(s):

Pancreatic Cancer ◽

Ascorbic Acid ◽

High Dose ◽

Abstract CT163: A Phase Ib/II trial of high dose ascorbic acid (AA) + paclitaxel protein bound (PP) + cisplatin (C) + gemcitabine (G) in patients (pts) with metastatic pancreatic cancer (MPC)

10.1158/1538-7445.sabcs18-ct163 ◽

2019 ◽

Author(s):

Gayle S. Jameson ◽

Erkut H. Borazanci ◽

Joshua D. Rabinowitz ◽

David Propper ◽

Karen Ansaldo ◽

...

Keyword(s):

Pancreatic Cancer ◽

Ascorbic Acid ◽

High Dose ◽

Abstract PO-015: A phase Ib/II trial of high dose ascorbic acid (AA) + paclitaxel protein bound (PP) + cisplatin (C) + gemcitabine (G) in patients (pts) with previously untreated metastatic pancreatic cancer (MPC)

10.1158/1538-7445.panca21-po-015 ◽

2021 ◽

Author(s):

Gayle S. Jameson ◽

Erkut H. Borazanci ◽

Daniel D. Von Hoff ◽

Joshua D. Rabinowitz ◽

Michael S. Gordon ◽

...

Keyword(s):

Pancreatic Cancer ◽

Ascorbic Acid ◽

High Dose ◽

Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer

PLoS ONE ◽

10.1371/journal.pone.0029794 ◽

2012 ◽

Vol 7 (1) ◽

pp. e29794 ◽

Cited By ~ 129

Author(s):

Daniel A. Monti ◽

Edith Mitchell ◽

Anthony J. Bazzan ◽

Susan Littman ◽

George Zabrecky ◽

...

Keyword(s):

Pancreatic Cancer ◽

Ascorbic Acid ◽

Phase I ◽

Intravenous Ascorbic Acid

A Phase I Clinical Trial of Ascorbic Acid and Gemcitabine for the Treatment of Metastatic Pancreatic Cancer

Free Radical Biology and Medicine ◽

10.1016/j.freeradbiomed.2011.10.342 ◽

2011 ◽

Vol 51 ◽

pp. S130

Author(s):

Jessemae Welsh ◽

Brett Wagner ◽

Pamela Zehr ◽

Daniel Berg ◽

Thorvardur Halfdanarson ◽

...

Keyword(s):

Pancreatic Cancer ◽

Clinical Trial ◽

Ascorbic Acid ◽

Phase I ◽

Phase I Clinical Trial ◽

Metastatic Pancreatic Cancer

An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer

Case Medical Research ◽

10.31525/ct1-nct03989310 ◽

2019 ◽

Author(s):

Keyword(s):

Pancreatic Cancer ◽

Phase I ◽

Open Label ◽

Open Label Phase ◽

Local Advanced

Faculty Opinions recommendation of FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.10667956.11678055 ◽

2011 ◽

Author(s):

Weijing Sun ◽

Davendra Sohal

Keyword(s):

Pancreatic Cancer ◽

Metastatic Pancreatic Cancer